Global Neuromodulation Market - Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Sep 2019
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Neuromodulation Market By Technology (Internal Neuromodulation, External Neuromodulation), Application (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation, Respiratory Electrical Stimulation), Biomaterial (Ceramics Biomaterials, Metallic Biomaterials, Polymeric Biomaterials) End User (Hospitals, Clinics, Home Healthcare), Geography (North America, South America, Europe, Asia-Pacific, Middle East & Africa) - Industry Trends and Forecast to 2026

Market Analysis: Global Neuromodulation Market

Global neuromodulation market is registering a healthy CAGR of 13.50% in the forecast period of 2019-2026. This rise in the market value can be attributed due to rise in geriatric population and their vulnerability to neurological disorders. The expansion in emerging economies is likely to drive the market growth.

Market Definition: Global Neuromodulation Market

Neuromodulation is a technology that directly reacts on the nerves. It is the delivery of stimulus directly to the target area. It is very effective as it can treat almost every disease from headache to spinal cord damage. The therapy provides relief from pain and steer away the side effects. Some of its applications are spinal cord stimulation, deep brain simulation, and sacral nerve stimulation. Electrodes are attached to the brain to carry out the procedure.

Market Drivers

  • Surge in the number of incidences of neurological disorders, will fuel the market growth
  • Remarkable growth in the numbers of aging population worldwide, is driving the market growth
  • Strapping product pipeline, is driving the growth of the market
  • The expanding target applications and new indications, is driving the neuromodulation market
  • Growing investments by government as well as private institutions in healthcare industry, is driving the market

Market Restraints

  • Lack of trained professionals, is restricting the growth of the market
  • Unfavorable reimbursement policies, are hindering the growth of the market
  • High capital investments and stringent government regulations, is restricting the growth of the market

Segmentation: Global Neuromodulation Market

By Technology

  • Internal Neuromodulation

    • Spinal Cord Stimulation
    • Deep Brain Stimulation
    • Vagus Nerve Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation

  • External Neuromodulation

    • Transcutaneous Electrical Nerve Stimulation
    • Transcranial Magnetic Stimulation
    • Respiratory Electrical Stimulation

By Application

  • Spinal Cord Stimulation

    • Failed Back Syndrome
    • Chronic Pain
    • Ischemia                     

  • Deep Brain Stimulation

    • Parkinson’s Disease
    • Tremor
    • Depression
    • Other

  • Sacral Nerve Stimulation

    • Urine Incontinence
    • Fecal Incontinence

  • Vagus Nerve Stimulation Market

    • Epilepsy
    • Other

  • Gastric Electrical Stimulation Market

    • Gastroparesis
    • Obesity

  • Transcutaneous Electrical Nerve Stimulation

    • Treatment Resistant Depression
    • Other

  • Repetitive Transcranial Magnetic Stimulation

    • Depression
    • Migraine Headache

  • Respiratory Electrical Stimulation

    • Spinal Cord Injury                   

By Biomaterial

  • Ceramics Biomaterials
  • Metallic Biomaterials
  • Polymeric Biomaterials

By End User

  • Hospitals
  • Clinics
  • Home Healthcare

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • South America

    • Brazil
    • Rest of South America

  • Europe

    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Malaysia
    • Indonesia
    • Thailand
    • Philippines
    • Rest of Asia-Pacific

  • Middle East & Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In August 2017, the U.S. Food and Drug Administration has cleared Stimpod NMS460 non-invasive neuromodulation device of Xavant Technology which is used to treat the chronic intractable pain.  It will become a valuable asset for the treatment in the U.S among physical therapists, physiatrists and many others as well as it will expand the company offerings.
  • In January 2017, Abbott completed the acquisition of St. Jude Medical Inc., which expanded opportunities for future growth and was a major step to develop company’s diverse portfolio of devices as well as strengthening the positon in the neuromodulation market globally.

Competitive Analysis:

Global neuromodulation market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of neuromodulation market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major market competitors currently working in the global neuromodulation market are Medtronic, Abbott, Boston Scientific Corporation, Cyberonics Inc., Cochlear Ltd., Advanced Bionics AG, Sonova, Nevro Corp., Neuronetics, Integer Holdings Corporation, Synapse Biomedical Inc., NeuroPace, Inc., NeuroSigma, Inc., Magstim, Soterix Medical Inc., LivaNova PLC, ALEVA NEUROTHERAPEUTICS SA, Bioness Inc., ReShape Lifesciences, Inc., DynaMD, BioAlps, The Axonics SNM System, MED-EL, LABORIE, Johnson & Johnson Services Inc., Functional Neuromodulation, Ltd., Stimwave LLC, Biegler GmbH among others.

Research Methodology: Global Neuromodulation Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others

Reasons to Purchase this Report

  • Current and future of global neuromodulation market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19